Annual Total Long Term Liabilities
$202.00 K
-$8.61 M-97.71%
December 31, 2024
Summary
- As of March 10, 2025, NAMS annual total long term liabilities is $202.00 thousand, with the most recent change of -$8.61 million (-97.71%) on December 31, 2024.
- During the last 3 years, NAMS annual total long term liabilities has risen by +$76.30 thousand (+60.70%).
- NAMS annual total long term liabilities is now -98.37% below its all-time high of $12.37 million, reached on December 31, 2022.
Performance
NAMS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$202.00 K
-$18.87 M-98.94%
December 31, 2024
Summary
- As of March 10, 2025, NAMS quarterly total long term liabilities is $202.00 thousand, with the most recent change of -$18.87 million (-98.94%) on December 31, 2024.
- Over the past year, NAMS quarterly long term liabilities has dropped by -$18.87 million (-98.94%).
- NAMS quarterly long term liabilities is now -98.94% below its all-time high of $19.07 million, reached on September 30, 2024.
Performance
NAMS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NAMS Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -97.7% | -98.9% |
3 y3 years | +60.7% | -98.9% |
5 y5 years | +100.0% | -98.9% |
NAMS Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.4% | +60.7% | -98.9% | +60.7% |
5 y | 5-year | -98.4% | -100.0% | -98.9% | +60.7% |
alltime | all time | -98.4% | -100.0% | -98.9% | +60.7% |
NewAmsterdam Pharma Company NV Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $202.00 K(-97.7%) | $202.00 K(-98.9%) |
Sep 2024 | - | $19.07 M(+36.8%) |
Jun 2024 | - | $13.94 M(-17.7%) |
Mar 2024 | - | $16.93 M(+92.3%) |
Dec 2023 | $8.81 M | $8.81 M(-22.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $11.41 M(-7.8%) |
Dec 2022 | $12.37 M(+9744.1%) | $12.37 M(+57.3%) |
Jun 2022 | - | $7.87 M(+6157.6%) |
Dec 2021 | $125.70 K(>+9900.0%) | $125.70 K |
Dec 2020 | $0.00 | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total long term liabilities?
- What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual total long term liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly long term liabilities year-on-year change?
What is NewAmsterdam Pharma Company NV annual total long term liabilities?
The current annual total long term liabilities of NAMS is $202.00 K
What is the all time high annual total long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total long term liabilities is $12.37 M
What is NewAmsterdam Pharma Company NV annual total long term liabilities year-on-year change?
Over the past year, NAMS annual total long term liabilities has changed by -$8.61 M (-97.71%)
What is NewAmsterdam Pharma Company NV quarterly total long term liabilities?
The current quarterly long term liabilities of NAMS is $202.00 K
What is the all time high quarterly long term liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total long term liabilities is $19.07 M
What is NewAmsterdam Pharma Company NV quarterly long term liabilities year-on-year change?
Over the past year, NAMS quarterly total long term liabilities has changed by -$18.87 M (-98.94%)